Antiemetics and antinauseants are medications employed in the prevention or management of vomiting resulting from emetogenic chemotherapy and for addressing postoperative nausea and vomiting. These drugs are effective in preventing, controlling, or treating nausea and vomiting triggered by various factors, including other medications, motion sickness, infections, stomach flu, or chemotherapy. Their mechanism of action involves blocking signal messages to the brain's nausea and vomiting control center, thus alleviating the symptoms.
The primary categories of drugs within the realm of antiemetics and antinauseants encompass dopamine antagonists, NK1 receptor antagonists, antihistamines (H1 histamine receptor antagonists), cannabinoids, benzodiazepines, anticholinergics, steroids, 5-HT3 receptor antagonists, and others. Dopamine antagonists, also known as anti-dopaminergics or dopamine receptor antagonists, function by blocking dopamine receptors and find applications in chemotherapy, motion sickness, gastroenteritis, general anesthetics, opioid analgesics, dizziness, pregnancy, food poisoning, emotional stress, and various other contexts. These medications are utilized in diverse healthcare settings, including hospitals, medical centers, clinics, and research institutes.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.
The antiemetics and antinauseants market research report are one of a series of new reports from The Business Research Company that provides antiemetics and antinauseants market statistics, including antiemetics and antinauseants industry global market size, regional shares, competitors with antiemetics and antinauseants market share, detailed antiemetics and antinauseants market segments, market trends and opportunities, and any further data you may need to thrive in the antiemetics and antinauseants industry. This antiemetics and antinauseants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The antiemetics and antinauseants market size has grown steadily in recent years. It will grow from $8.19 billion in 2024 to $8.48 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to historical branding and market competition, historical treatment preferences, economic conditions, historical global health events, medical advancements and research.
The antiemetics and antinauseants market size is expected to see steady growth in the next few years. It will grow to $9.64 billion in 2029 at a compound annual growth rate (CAGR) of 3.3%. The growth in the forecast period can be attributed to research and development initiatives, economic factors, market competition and industry trends, changing disease patterns, healthcare policies and regulations. Major trends in the forecast period include increased focus on patient experience, changing healthcare policies, consumer preference for non-invasive treatments, rising prevalence of chemotherapy and pregnancy-related nausea, emergence of targeted therapies.
The forecast of 3.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for oncology centers by increasing costs of 5-HT3 receptor antagonists like ondansetron imported from China and Italy, potentially reducing chemotherapy support options and raising cancer care expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The antiemetics and antinauseants market is propelled by the rising prevalence of cancer. Chemotherapy is one of the most commonly recommended treatments for cancer, and chemotherapy-induced nausea and vomiting (CINV) are among its side effects. Antiemetics can help prevent CINV in approximately 60%-70% of patients. For instance, in April 2024, the American Cancer Society, a non-profit organization based in the United States, projected around 609,000 cancer-related deaths and anticipated 1.9 million new cancer cases identified in the country in 2022. An estimated 620,000 cancer deaths are expected, indicating a slight increase in mortality rates for 2024. As the incidence of cancer rises, the demand for antiemetics and antinauseants will increase, thereby boosting market revenue.
The growing prevalence of tuberculosis is anticipated to drive the expansion of the antiemetics and antinauseants market. Tuberculosis (TB) is an infectious bacterial disease that primarily affects the lungs. Antiemetics and antinauseants are used to manage nausea and vomiting caused by anti-tuberculosis medications. For instance, in November 2023, the Global Tuberculosis Report 2023 published by the World Health Organization, a Switzerland-based intergovernmental organization, stated that approximately 10.6 million individuals (with a 95% uncertainty interval of 9.9 to 11.4 million) contracted tuberculosis globally in 2022, up from 10.3 million cases in 2021. Thus, the increased prevalence of tuberculosis is expected to drive growth in the antiemetics and antinauseants market.
Major companies in the antiemetic and antinauseant markets are focusing on new product innovations, such as ready-to-use injectables, to simplify treatment processes and improve patient compliance. These ready-to-use formulations are designed for immediate effectiveness, minimizing the time and complexity associated with traditional injectable medications. For example, in July 2024, Amneal Pharmaceuticals, a US-based specialty pharmaceutical company, introduced FOCINVEZ, the first ready-to-use injectable formulation of fosaprepitant aimed at preventing acute and delayed nausea and vomiting related to highly emetogenic cancer chemotherapy. This product comes in a 150 mg/50 mL vial, is free of Polysorbate 80, and requires no reconstitution or dilution, enabling direct administration. FOCINVEZ is approved for use in adults and pediatric patients aged six months and older and has received a unique J-Code (J1434) for reimbursement.
Government agencies such as the US Food and Drug Administration (FDA) regulate the antiemetics and antinauseants market. In the USA, specific regulations outlined in title 21 of the FDA's Department of Health and Human Services govern the conditions that antiemetic and antinauseant drugs must fulfill to remain in the market, covering definitions, regulations, and labeling requirements.
Major companies in the antiemetic and antinauseant markets are focusing on new product innovations, such as metal-free nasal spray pumps, to address customer needs in the market. A metal-free nasal spray pump is a dispensing device designed without metal components, ensuring compatibility with sensitive formulations like saline solutions or pharmaceutical sprays. For example, in January 2023, Aptar Pharma, a US-based company that specializes in designing and manufacturing drug delivery systems, introduced the APF Futurity nasal spray pump to meet the growing demand for sustainable, recyclable pharmaceutical packaging. With a metal-free design for easier recycling, the APF Futurity has achieved Class A recyclability certification in European streams. Its user-friendly design allows for disposal as a single unit, while advanced dosing technology ensures accurate delivery. This innovative pump integrates Aptar's Advanced Preservative-Free (APF) technology with improved recyclability, providing a sustainable yet high-performance packaging solution.
Major companies operating in the antiemetics and antinauseants market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy's Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA
North America was the largest region in the antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the antiemetics and antinauseants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The antiemetics and antinauseants market consists of sales of dopamine, serotonin, neurokinin, histamine, and acetylcholine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Antiemetics And Antinauseants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on antiemetics and antinauseants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for antiemetics and antinauseants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The antiemetics and antinauseants market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drug: Dopamine antagonists; NK1 receptor antagonist; Antihistamines (H1 histamine receptor antagonists); Cannabinoids; Benzodiazepines; Anticholinergics; Steroids; 5-HT3 receptor antagonists; Other Drug Types
- 2) By Application: Chemotherapy; Motion sickness; Gastroenteritis; General anesthetics; Opioid analgesics; Dizziness; Pregnancy; Food poisoning; Emotional stress; Other Application Types
- 3) By End Users: Hospital; Medical Center; Clinic; Research Institutes
- Subsegments:
- 1) By Dopamine Antagonists: Metoclopramide; Prochlorperazine; Domperidone
- 2) By NK1 Receptor Antagonists: Aprepitant; Fosaprepitant; Rolapitant
- 3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate; Meclizine; Diphenhydramine
- 4) By Cannabinoids: Dronabinol; Nabilone
- 5) By Benzodiazepines: Lorazepam; Diazepam
- 6) By Anticholinergics: Scopolamine; Glycopyrrolate
- 7) By Steroids: Dexamethasone; Methylprednisolone
- 8) By 5-HT3 Receptor Antagonists: Ondansetron; Granisetron; Palonosetron
- 9) By Other Drug Types: Herbal Remedies; Acupressure Devices
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Merck & Co. Inc.; Bayer AG; Novartis AG; Sanofi SA; AstraZeneca plc; Abbott Laboratories; GlaxoSmithKline plc; Cipla Ltd.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd.; Baxter International Inc.; Teva Pharmaceutical Industries Ltd.; Astellas Pharma Inc.; Kyowa Hakko Kirin Pharma Co. Ltd.; Daiichi Sankyo Company; Braun GmbH; Eisai Co. Ltd.; Sun Pharmaceuticals Industries Ltd.; Dr. Reddy's Laboratories; Hikma Pharmaceuticals plc; IPCA Laboratories Ltd.; Eagle Pharmaceuticals Inc.; Cadila Pharmaceuticals Ltd.; Bristol Laboratories Ltd.; Tesaro Inc.; SRS Pharmaceuticals Pvt. Ltd.; Acacia Pharma Ltd.; Algen Healthcare Ltd.; Mirabilia Sciences Pvt. Ltd.; Helsinn Healthcare SA
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Antiemetics And Antinauseants Market Characteristics
3. Antiemetics And Antinauseants Market Trends And Strategies
4. Antiemetics And Antinauseants Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Antiemetics And Antinauseants Growth Analysis And Strategic Analysis Framework
- 5.1. Global Antiemetics And Antinauseants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Antiemetics And Antinauseants Market Growth Rate Analysis
- 5.4. Global Antiemetics And Antinauseants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Antiemetics And Antinauseants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Antiemetics And Antinauseants Total Addressable Market (TAM)
6. Antiemetics And Antinauseants Market Segmentation
- 6.1. Global Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dopamine antagonists
- NK1 receptor antagonist
- Antihistamines (H1 histamine receptor antagonists)
- Cannabinoids
- Benzodiazepines
- Anticholinergics
- Steroids
- 5-HT3 receptor antagonists
- Other Drug Types
- 6.2. Global Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chemotherapy
- Motion sickness
- Gastroenteritis
- General anesthetics
- Opioid analgesics
- Dizziness
- Pregnancy
- Food poisoning
- Emotional stress
- Other Application Types
- 6.3. Global Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital
- Medical Center
- Clinic
- Research Institutes
- 6.4. Global Antiemetics And Antinauseants Market, Sub-Segmentation Of Dopamine Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Metoclopramide
- Prochlorperazine
- Domperidone
- 6.5. Global Antiemetics And Antinauseants Market, Sub-Segmentation Of NK1 Receptor Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Aprepitant
- Fosaprepitant
- Rolapitant
- 6.6. Global Antiemetics And Antinauseants Market, Sub-Segmentation Of Antihistamines (H1 Histamine Receptor Antagonists), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dimenhydrinate
- Meclizine
- Diphenhydramine
- 6.7. Global Antiemetics And Antinauseants Market, Sub-Segmentation Of Cannabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dronabinol
- Nabilone
- 6.8. Global Antiemetics And Antinauseants Market, Sub-Segmentation Of Benzodiazepines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Lorazepam
- Diazepam
- 6.9. Global Antiemetics And Antinauseants Market, Sub-Segmentation Of Anticholinergics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Scopolamine
- Glycopyrrolate
- 6.10. Global Antiemetics And Antinauseants Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dexamethasone
- Methylprednisolone
- 6.11. Global Antiemetics And Antinauseants Market, Sub-Segmentation Of 5-HT3 Receptor Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Ondansetron
- Granisetron
- Palonosetron
- 6.12. Global Antiemetics And Antinauseants Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Herbal Remedies
- Acupressure Devices
7. Antiemetics And Antinauseants Market Regional And Country Analysis
- 7.1. Global Antiemetics And Antinauseants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Antiemetics And Antinauseants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Antiemetics And Antinauseants Market
- 8.1. Asia-Pacific Antiemetics And Antinauseants Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Antiemetics And Antinauseants Market
- 9.1. China Antiemetics And Antinauseants Market Overview
- 9.2. China Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Antiemetics And Antinauseants Market
- 10.1. India Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Antiemetics And Antinauseants Market
- 11.1. Japan Antiemetics And Antinauseants Market Overview
- 11.2. Japan Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Antiemetics And Antinauseants Market
- 12.1. Australia Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Antiemetics And Antinauseants Market
- 13.1. Indonesia Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Antiemetics And Antinauseants Market
- 14.1. South Korea Antiemetics And Antinauseants Market Overview
- 14.2. South Korea Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Antiemetics And Antinauseants Market
- 15.1. Western Europe Antiemetics And Antinauseants Market Overview
- 15.2. Western Europe Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Antiemetics And Antinauseants Market
- 16.1. UK Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Antiemetics And Antinauseants Market
- 17.1. Germany Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Antiemetics And Antinauseants Market
- 18.1. France Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Antiemetics And Antinauseants Market
- 19.1. Italy Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Antiemetics And Antinauseants Market
- 20.1. Spain Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Antiemetics And Antinauseants Market
- 21.1. Eastern Europe Antiemetics And Antinauseants Market Overview
- 21.2. Eastern Europe Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Antiemetics And Antinauseants Market
- 22.1. Russia Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Antiemetics And Antinauseants Market
- 23.1. North America Antiemetics And Antinauseants Market Overview
- 23.2. North America Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Antiemetics And Antinauseants Market
- 24.1. USA Antiemetics And Antinauseants Market Overview
- 24.2. USA Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Antiemetics And Antinauseants Market
- 25.1. Canada Antiemetics And Antinauseants Market Overview
- 25.2. Canada Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Antiemetics And Antinauseants Market
- 26.1. South America Antiemetics And Antinauseants Market Overview
- 26.2. South America Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Antiemetics And Antinauseants Market
- 27.1. Brazil Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Antiemetics And Antinauseants Market
- 28.1. Middle East Antiemetics And Antinauseants Market Overview
- 28.2. Middle East Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Antiemetics And Antinauseants Market
- 29.1. Africa Antiemetics And Antinauseants Market Overview
- 29.2. Africa Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Antiemetics And Antinauseants Market Competitive Landscape And Company Profiles
- 30.1. Antiemetics And Antinauseants Market Competitive Landscape
- 30.2. Antiemetics And Antinauseants Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
31. Antiemetics And Antinauseants Market Other Major And Innovative Companies
- 31.1. Sanofi SA
- 31.2. AstraZeneca plc
- 31.3. Abbott Laboratories
- 31.4. GlaxoSmithKline plc
- 31.5. Cipla Ltd.
- 31.6. Eli Lilly and Company
- 31.7. F. Hoffmann-La Roche Ltd.
- 31.8. Baxter International Inc.
- 31.9. Teva Pharmaceutical Industries Ltd.
- 31.10. Astellas Pharma Inc.
- 31.11. Kyowa Hakko Kirin Pharma Co. Ltd.
- 31.12. Daiichi Sankyo Company
- 31.13. Braun GmbH
- 31.14. Eisai Co. Ltd.
- 31.15. Sun Pharmaceuticals Industries Ltd.
32. Global Antiemetics And Antinauseants Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Antiemetics And Antinauseants Market
34. Recent Developments In The Antiemetics And Antinauseants Market
35. Antiemetics And Antinauseants Market High Potential Countries, Segments and Strategies
- 35.1 Antiemetics And Antinauseants Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Antiemetics And Antinauseants Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Antiemetics And Antinauseants Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
